Second quarter and half year results 2014
31 July 2014
Download our second quarter 2014 presentation and clinical trial programmes summary.
Strategic Transaction with Almirall
30 July 2014
AstraZeneca announced that it has entered an agreement to transfer to the company the rights to Almirall’s respiratory franchise for an initial consideration of $875 million on completion, and up to $1.22 billion in development, launch, and sales-related milestones. AstraZeneca has also agreed to make various sales-related payments.
American Society of Clinical Oncology
3 June 2014
American Thoracic Society AstraZeneca Analyst briefing
20 May 2014
AstraZeneca hosted a briefing for analysts and investors during the American Thoracic Society (ATS) congress held in San Diego on Tuesday 20th May 2014.
Teleconference replay details
UK freephone: 0800 953 1533
US freephone: 866 247 4222
Sweden freephone: 0200 890171
International: +44 (0) 1452 550000
Conference code: 30378840
The replay will be available from 21st May – 17th June 2014.
An mp3 transcript of this call is now available.View the webcast
AstraZeneca strategy update
6 May 2014
WebcastView the webcast
First quarter results 2014
24 April 2014
Download our first quarter 2014 press release, development pipeline table and presentation.
A recording of the analyst teleconference is now available to download using the link below.View the webcast